A guide to murine platelet structure, function, assays, and genetic alterations
A guide to murine coagulation factor structure, function, assays, and genetic alterations
A guide to murine fibrinolytic factor structure, function, assays, and genetic alterations
Venous thromboembolism and the concepts of the incidence and mortality
Incidence and mortality of venous thrombosis
Homozygosity for the C46T polymorphism of the F12 gene is a risk factor for venous thrombosis during the first pregnancy
Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders
Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease
A common 253-kb deletion involving VWF and TMEM16B in German and Italian patients with severe von Willebrand disease type 3
The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trials
Increased platelet, leukocyte, and endothelial cell activity are associated with increased coagulability in patients after total knee arthroplasty
A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement
Ethnic differences in cardiovascular risk factors in healthy Caucasian and South Asian individuals with the metabolic syndrome
Indices of platelet activation and the stability of coronary artery disease
Elevated plasma fibrinogen γ′ concentration is associated with myocardial infarction
Preferential localization of recombinant factor VIIa to platelets activated with a combination of thrombin and a glycoprotein VI receptor agonist
A cross-reactive material positive variant of coagulation factor XI (FXIP520L) with a catalytic defect
Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusion
A mechanism to safeguard platelet adhesion under high shear flow
The regulation by fibrinogen and fibrin of tissue plasminogen activator kinetics and inhibition by plasminogen activator inhibitor 1
TAFIa, PAI-1 and α2-antiplasmin
Neuroprotective effect of cilostazol against retinal ischemic damage via inhibition of leukocyte–endothelial cell interactions
Characterization of endothelial-like cells derived from human mesenchymal stem cells
Insulin-like growth factor binding protein-3 induces angiogenesis through IGF-I- and SphK1-dependent mechanisms
Identification of key residues involved in mediating the in vivo anti-tumor/anti-endothelial activity of Alphastatin
Preanalytical conditions that affect coagulation testing, including hormonal status and therapy
JAK2 V617F is specifically associated with idiopathic splanchnic vein thrombosis
Prognostic value of annexin A5 −1 C/T polymorphism in a long term follow-up after premature myocardial infarction
Plasma fibronectin levels and coronary artery disease
Hyperbilirubinemia interferes with ADAMTS-13 activity measurement by FRETS-VWF73 assay
von Willebrand factor collagen binding assay with a commercial kit using type III collagen in von Willebrand disease type 2
Standardization of circulating endothelial cell enumeration by the use of human umbilical vein endothelial cells
Influence of the Thr325Ile polymorphism on procarboxypeptidase U (thrombin-activable fibrinolysis inhibitor) activity-based assays
Dietary supplement use among anticoagulation clinic patients
Incidence of five prothrombotic gene polymorphisms in healthy Saudi Arabians
Ticlopidine could be an alternative therapy in the case of pharmacological resistance to clopidogrel
The flow cytometric VASP assay can be used to determine the effectiveness of clopidogrel in patients treated with abciximab
Evaluation of the platelet response to clopidogrel with light transmittance aggregometry
In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban